Top > Search of International Patents > Bacterial cell component-unresponsive model mouse

Bacterial cell component-unresponsive model mouse achieved

Foreign code F110005028
File No. A031-19US
Posted date Aug 18, 2011
Country United States of America
Application number 88932400
Gazette No. 7078585
Date of filing Jan 13, 2000
Gazette Date Jul 18, 2006
International application number JP2000000132
International publication number WO2000041561
Date of international filing Jan 13, 2000
Date of international publication Jul 20, 2000
Priority data
  • P1999-007365 (Jan 14, 1999) JP
  • P1999-228282 (Aug 12, 1999) JP
  • P1999-309238 (Oct 29, 1999) JP
  • 2000WO-JP00132 (Jan 13, 2000) WO
Title Bacterial cell component-unresponsive model mouse achieved
Abstract (US7078585)
A knockout mouse which is unresponsive to peptidoglycan, a lipoprotein/lipopeptide and the like, and is useful for elucidating the contribution of individual members of the TLR family to a signaling stimulated with bacterial cell components in vivo, in particular, the role of TLR2 and MyD88 in vivo.
A bacterial cell component-unresponsive knockout mouse is generated by a process comprising the steps of: a targeting vector is constructed by replacing a whole or a part of a gene fragment of an exon region containing a cytoplasmic region of TLR2 or MyD88 gene and the like with a plasmid having a poly A signal and a marker gene; the targeting vector is introduced into an embryonic stem cell; the targeting embryonic stem cell having a homologously recombined TLR2 or MyD88 gene is microinjected into the blastocyst of a mouse and the blastocyst is put back into the uterus of a recipient mouse.
Scope of claims [claim1]
1. A mouse comprising homozygous disruption of TLR2 gene in its genome, wherein such disruption results in no production of endogenous TLR2 protein, and wherein said mouse exhibits the phenotype of being unresponsive to bacterial cell component(s) that is a lipoprotein/lipopeptide.
[claim2]
2. The mouse according to claim 1, wherein a lipoprotein/lipopeptide is a macrophage-activating lipopeptide obtained from bacteria which belong to Mycoplasma.
[claim3]
3. The mouse according to claim 1 that is further unresponsive to peptidoglycan as a bacterial cell component.
[claim4]
4. The mouse according to claim 1 that is further hyporesponsive to a cell wall fraction of Gram-positive bacteria.
[claim5]
5. A mouse comprising homozygous disruption of MyD88 gene in its genome, wherein such disruption results in no production of endogenous MyD88 protein, and wherein said mouse exhibits the phenotype of being unresponsive to bacterial cell component(s) that is a lipoprotein/lipopeptide.
[claim6]
6. The mouse according to claim 5, wherein a lipoprotein/lipopeptide is a macrophage-activating lipopeptide obtained from bacteria which belong to Mycoplasma.
[claim7]
7. The mouse according to claim 5 that is further unresponsive to peptidoglycan as a bacterial cell component.
[claim8]
8. The mouse according to claim 5 that is further unresponsive to a cell wall fraction of Gram-positive bacteria.
[claim9]
9. The mouse according to claim 5 that is further unresponsive to endotoxin as a bacterial cell component.
[claim10]
10. The mouse according to claim 5 that is further unresponsive to lipoteichoic acid as a bacterial cell component.
[claim11]
11. The mouse according to claim 5 that is further unresponsive to Mycobacterium tuberculosis lysate as a bacterial cell component.
  • Inventor, and Inventor/Applicant
  • AKIRA SHIZUO
  • TAKEUCHI OSAMU
  • TAKEDA KIYOSHI
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
IPC(International Patent Classification)
Reference ( R and D project ) CREST Host Defense Mechanism AREA
Please contact us by E-mail or facsimile if you have any interests on this patent.

PAGE TOP

close
close
close
close
close
close